A new doctoral thesis reveals that immunity from COVID-19 lasts significantly longer than initially expected, with most individuals retaining antibodies for at least two years.
A recent doctoral thesis from Sykehuset Telemark in Norway indicates that resilience following COVID-19 may last longer than previously believed. The study examined a group of 400 unvaccinated individuals, reporting that 96% still had antibodies one year after contracting the virus. Notably, none of the participants displayed symptoms of a new coronavirus infection within that first year, and the majority continued to show antibody presence even two years after their initial illness.
The findings underscore the long-lasting nature of natural immunity obtained from past infection, offering a counterpoint to earlier theories that suggested immunity wanes quickly. Additionally, the research highlights the importance of vaccinations, asserting that while natural immunity is significant, vaccinated individuals enjoy a strengthened protection against reinfection, especially when booster doses are administered. This could have important implications for public health policies regarding COVID-19 recovery and vaccination strategies.
Conducted by Marjut Anneli Sarjomaa, the study holds considerable importance in ongoing discussions about post-COVID health outcomes and vaccine efficacy. As nations continue to navigate and mitigate the effects of the pandemic, these findings could lead to revised guidelines addressing immunity duration and the importance of booster vaccinations, potentially shaping future public health recommendations in Norway and beyond.
